FluoroPharma Medical, Inc.

FluoroPharma Medical, Inc.

Sector: In Vitro And In Vivo Diagnostic Substances Region: NJ, United States

: | OTC Markets: FPMI

Similar to: bioMérieux SA, Vitrolife AB, Bio-Techne

FluoroPharma Medical, Inc. is a biopharmaceutical company, which specializes in discovering, developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. It has two clinical-stage molecular imaging pharmaceutical product candidates: CardioPET and BFPET. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.

News & Analysis

You may also be interested in: